Authors

• Tamar E. C. Nijsten (ORCID: https://orcid.org/0000-0001-9940-2875)
• Celeste J Eggermont (ORCID: https://orcid.org/0000-0002-1669-0283)
• Quirinus J.M. Voorham
• Mathilde Jalving (ORCID: https://orcid.org/0000-0002-9142-9050)
• Marieke W.J. Louwman (ORCID: https://orcid.org/0000-0001-9011-6741)
• Meggie M.C.M. Drissen (ORCID: https://orcid.org/0000-0002-5742-8011)
• K. Schreuder (ORCID: https://orcid.org/0000-0002-4224-800X)
• Antien L. Mooyaart (ORCID: https://orcid.org/0000-0001-9810-5780)
• Dirk J. Grünhagen (ORCID: https://orcid.org/0000-0001-8293-6002)
• Annette H. Bruggink (ORCID: https://orcid.org/0000-0003-1354-6988)
• Marlies Wakkee (ORCID: https://orcid.org/0000-0001-8578-901X)
• Loes M. Hollestein (ORCID: https://orcid.org/0000-0001-8922-6791)
• Olivia F M Steijlen (ORCID: https://orcid.org/0000-0002-9183-9287)

Institutions

• University Medical Center Groningen (NL)
• Netherlands Comprehensive Cancer Organisation (NL)
• Erasmus MC Cancer Institute (NL)

Publication Details

Journal

The Lancet Regional Health - Europe

Published

2025-10-18

DOI

https://doi.org/10.1016/j.lanepe.2025.101501

Citations

1

Primary Topic

Nonmelanoma Skin Cancer Studies

Type

article

Field-Weighted Citation Impact

1.35

Funders

• Sanofi
• Regeneron Pharmaceuticals
• Sanofi Genzyme